First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial

Yelena Y. Janjigian, Kohei Shitara, Markus Moehler, +26

The Lancet

Chemotherapy Versus ChemotherapyEsophageal CancerGastrointestinal OncologyMedicineCheckmate 649 +5

Results of a Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Trifluridine/Tipiracil (TAS-102) Monotherapy in Asian Patients With Previously Treated Metastatic Colorectal Cancer: The TERRA Study

Jianming Xu, Tae Won Kim, Lin Shen, +17

Journal of Clinical Oncology

Cancer ManagementPharmacotherapySurgeryGynecology OncologyOncology +16

Bevacizumab plus capecitabine and cisplatin in Chinese patients with inoperable locally advanced or metastatic gastric or gastroesophageal junction cancer: randomized, double-blind, phase III study (AVATAR study)

Lin Shen, Jin Li, Jianming Xu, +13

Gastric Cancer

Dynamic monitoring of circulating tumour cells to evaluate therapeutic efficacy in advanced gastric cancer

Yilin Li, Jifang Gong, Qiyue Zhang, +5

British Journal of Cancer

Safety and efficacy of fruquintinib in patients with previously treated metastatic colorectal cancer: a phase Ib study and a randomized double-blind phase II study

Rui‐Hua Xu, Jin Li, Yuxian Bai, +10

Journal of Hematology & Oncology

Establishment and characterization of patient-derived tumor xenograft using gastroscopic biopsies in gastric cancer

Yan Zhu, Tiantian Tian, Zhongwu Li, +10

Scientific Reports

Circulating tumor <scp>DNA</scp> functions as an alternative for tissue to overcome tumor heterogeneity in advanced gastric cancer

Jing Gao, Wanchun Zang, Beifang Li, +8

Cancer Science

Pertuzumab (P) + trastuzumab (H) + chemotherapy (CT) for HER2-positive metastatic gastric or gastro-oesophageal junction cancer (mGC/GEJC): Final analysis of a Phase III study (JACOB)

Josep Tabernero, Paulo M. Hoff, Lin Shen, +7

Annals of Oncology

Her2-positive Metastatic GastricGastrointestinal OncologyMedicineGastroenterologyPathology +6

Famitinib versus placebo in the treatment of refractory metastatic colorectal cancer: a multicenter, randomized, double-blinded, placebo-controlled, phase II clinical trial

Rui‐Hua Xu, Lin Shen, Ke‐Ming Wang, +18

Chinese Journal of Cancer

Pertuzumab in combination with trastuzumab and chemotherapy for Chinese patients with HER2‐positive metastatic gastric or gastroesophageal junction cancer: a subpopulation analysis of the JACOB trial

Tianshu Liu, Yanru Qin, Jin Li, +10

Cancer Communications